Pathogenic role of interleukin-6 in the development of sepsis. Part I: Study in a standardized contact burn murine model

Critical Care Medicine

Volumn 31, Issue 5, 2003, Pages 1490-1494

  Pallua, Norbert ^a   Von Heimburg, Dennis ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Burn; Cytokines; Endotoxin; Interleukin 6; Murine burn model; Sepsis

Indexed keywords

CYTOKINE; ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; INTERLEUKIN 6 RECEPTOR; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURN; CONTROLLED STUDY; CYTOKINE RELEASE; EXPERIMENTAL MODEL; HISTOPATHOLOGY; LETHALITY; LEUKOCYTE COUNT; MALE; MORTALITY; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; SEPSIS; SKIN INJURY; THROMBOCYTE COUNT;

ANIMALS; BODY SURFACE AREA; BURNS; DISEASE MODELS, ANIMAL; INFLAMMATION; INTERFERON TYPE II; INTERLEUKIN-6; LEUKOCYTE COUNT; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; PLATELET COUNT; PSEUDOMONAS INFECTIONS; RECEPTORS, INTERLEUKIN-6; SEPSIS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037566959     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000065724.51708.F5     Document Type: Article

References (32)

1. Shires GT: Evolution of trauma and trauma research. J Trauma 1990; 30S:107-115
2. McManus AT, Mason ADJ, McManus WF, et al: Twenty-five year review of Pseudomonas aeruginosa bacteremia in a burn center. Eur J Clin Microbiol 1985; 4:219-223
3. Guo Y, Dickerson C, Chrest FJ, et al: Increased levels of circulating interleukin 6 in burn patients. Clin Immunol Immunopathol 1990; 54:361-371
4. Drost AC, Burleson DG, Cioffi WG, et al: Plasma cytokines following thermal injury and their relationship with patient mortality, burn size, and time postburn. J Trauma 1993; 35:335-339
5. Endo S, Inada K, Yamada Y, et al: Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns. J Med 1996; 27:57-71
6. Carsin H, Assicot M, Feger F, et al: Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF alpha and endotoxin levels early after thermal injury. Burns 1997; 23:218-224
7. von Heimburg D, Stieghorst W, Khorram-Sefat R, et al: Procalcitonin: A sepsis parameter in severe burn injuries. Burns 1998; 24:745-750
8. Yamada Y, Endo S, Inada K: Plasma cytokine levels in patients with severe burn injury - with reference to the relationship between infection and prognosis. Burns 1996; 22:587-593
9. Neely AN, Hoover DL, Holder IA, et al: Circulating levels of tumour necrosis factor, interleukin 6 and proteolytic activity in a murine model of burn and infection. Burns 1996; 22:524-530
10. Kawakami M, Kaneko N, Anada H, et al: Measurement of interleukin-6, interleukin-10, and tumor necrosis factor-alpha levels in tissues and plasma after thermal injury in mice. Surgery 1997; 121:440-448
11. Kelly JL, O'Sullivan C, O'Riordain M, et al: Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury? Ann Surg 1997; 225:530-541
12. Youn YK, LaLonde C, Demling R: The role of mediators in the response to thermal injury. World J Surg 1992; 16:30-36
13. Wu JZ, Ogle CK, Mao JX, et al: The increased potential for the production of inflammatory cytokines by Kupffer cells and splenic macrophages eight days after thermal injury. Inflammation 1995; 19:529-541
14. Ogle CK, Valente JF, Guo X, et al: Thermal injury induces the development of inflammatory macrophages from nonadherent bone marrow cells. Inflammation 1997; 21:569-582
15. Morris DD, Henry MM, Moore JN, et al: Effect of dietary linolenic acid on endotoxin-induced thromboxane and prostacyclin production by equine peritoneal macrophages. Circ Shock 1989; 29:311-318
16. Tokyay R, Zeigler ST, Heggers JP, et al: Effects of anesthesia, surgery, fluid resuscitation, and endotoxin administration on post-burn bacterial translocation. J Trauma 1991; 31:1376-1379
17. Wichmann MW, Ayala A, Chaudry IH: Severe depression of host immune functions following closed-bone fracture, soft-tissue trauma, and hemorrhagic shock. Crit Care Med 1998; 26:1372-1378
18. Hu S, Sheng Z, Zhou B, et al: Study on delay two-phase multiple organ dysfunction syndrome. Chin Med J 1998; 111:101-108
19. Yaffe MB, Xu J, Burke PA, et al: Priming of the neutrophil respiratory burst is species-dependent and involves MAP kinase activation. Surgery 1999; 126:248-254
20. O'Riordain MG, O'Riordain DS, Molloy RG, et al: Dosage and timing of anti-TNF-alpha antibody treatment determine its effect of resistance to sepsis after injury. J Surg Res 1996; 64:95-101
21. Shoup M, He LK, Liu H, et al: Cyclooxygenase-2 inhibitor NS-398 improves survival and restores leukocyte counts in burn infection. J Trauma 1998; 45:215-220
22. Gennari R, Alexander JW, Pyles T, et al: Effects of antimurine interleukin-6 on bacterial translocation during gut-derived sepsis. Arch Surg 1994; 129:1191-1197
23. Walker HL, Mason HD: A standard animal burn. J Trauma 1968; 8:1049-1051
24. Schildt B, Nilsson A: Standardised burns in mice. Eur Surg Res 1970; 2:23-33
25. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101:1644-1655
26. Galanos C, Freudenberg M: Mechanisms of endotoxin shock and endotoxin hypersensitivity. Immunobiology 1993; 187:346-356
27. Zhou D, Munster AM, Winchurch RA: Inhibitory effects of interleukin 6 on immunity: Possible implications in burn patients. Arch Surg 1992; 127:65-69
28. Ertel W, Jarrar D, Jochum M, et al: Enhanced release of elastase is not concomitant with increased secretion of granulocyte-activating cytokines in whole blood from patients with sepsis. Arch Surg 1994; 129:90-97
29. Libert C, Vink A, Coulie P, et al: Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models. Eur J Immunol 1992; 22:2625-2630
30. Heinzel FP: The role of IFN-gamma in the pathology of experimental endotoxemia. J Immunol 1990; 145:2920-2924
31. Yoshimoto T, Nakanishi K, Hirose S, et al: High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-1/tumor necrosis factor. J Immunol 1992; 148:3596-3603
32. Catania RA, Chaudry IH: Immunological consequences of trauma and shock. Ann Acad Med Singapore 1999; 28:120-132